Sharps Compliance - SMED Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $6.50
  • Forecasted Upside: -25.71%
  • Number of Analysts: 4
  • Breakdown:
  • 0 Sell Ratings
  • 4 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$8.75
+0 (0.00%)
Get New Sharps Compliance Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for SMED and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for SMED

Analyst Price Target is $6.50
▼ -25.71% Downside Potential
This price target is based on 4 analysts offering 12 month price targets for Sharps Compliance in the last 3 months. The average price target is $6.50, with a high forecast of $7.00 and a low forecast of $6.00. The average price target represents a -25.71% upside from the last price of $8.75.

This chart shows the closing price for SMED for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Hold

The current consensus among 4 investment analysts is to hold stock in Sharps Compliance. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 5 hold ratings
  • 0 sell ratings
8/7/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 5 hold ratings
  • 0 sell ratings
11/5/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 5 hold ratings
  • 0 sell ratings
2/3/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 3 hold ratings
  • 0 sell ratings
5/4/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 5 hold ratings
  • 0 sell ratings
8/2/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 4 hold ratings
  • 0 sell ratings
10/31/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 4 hold ratings
  • 0 sell ratings
12/30/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 4 hold ratings
  • 0 sell ratings
1/29/2023

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 4 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
7/13/2022Stifel NicolausDowngradeBuy ➝ HoldLow
7/12/2022Lake Street CapitalDowngradeBuy ➝ HoldN/A
7/12/2022Barrington ResearchDowngradeOutperform ➝ Market PerformN/A
6/28/2022Barrington ResearchLower TargetOutperform$11.00 ➝ $6.00Low
4/5/2022Roth CapitalDowngradeBuy ➝ Neutral$12.00 ➝ $7.00High
11/3/2021Barrington ResearchReiterated RatingIn-LineLow
10/28/2021HC WainwrightReiterated RatingHoldLow
8/23/2021Barrington ResearchLower TargetOutperform ➝ Outperform$18.00 ➝ $13.00High
8/19/2021HC WainwrightDowngradeBuy ➝ NeutralMedium
5/7/2021Barrington ResearchBoost Target$15.00 ➝ $18.00Low
5/6/2021Barrington ResearchReiterated RatingOutperformHigh
4/29/2021HC WainwrightBoost TargetBuy$18.00 ➝ $25.00High
4/26/2021Roth CapitalBoost TargetBuy$16.00 ➝ $18.00Low
3/30/2021Stifel NicolausBoost TargetBuy$14.00 ➝ $16.00High
2/16/2021Lake Street CapitalBoost TargetBuy$13.00 ➝ $18.00Low
2/12/2021Barrington ResearchBoost TargetOutperform$13.00 ➝ $15.00Low
1/29/2021Barrington ResearchBoost TargetPositive ➝ Outperform$9.00 ➝ $13.00Low
1/29/2021HC WainwrightBoost TargetBuy$12.00 ➝ $18.00High
12/18/2020HC WainwrightInitiated CoverageBuy$12.00Medium
10/28/2020Stifel NicolausLower TargetBuy$11.50 ➝ $11.00Low
8/21/2020Barrington ResearchReiterated RatingBuy$9.00Medium
7/15/2020Lake Street CapitalInitiated CoverageBuy$10.00High
4/30/2020Barrington ResearchBoost TargetOutperform$6.00 ➝ $7.50High
4/8/2020Stifel NicolausBoost TargetBuy$6.00 ➝ $9.00High
2/2/2020Stifel NicolausUpgradeHold ➝ Buy$4.50 ➝ $6.00Low
1/29/2020Barrington ResearchReiterated RatingBuy$6.00Medium
10/29/2019Barrington ResearchReiterated RatingOutperform$5.00 ➝ $6.00Medium
7/24/2019Robert W. BairdInitiated CoverageBuy$4.50High
7/24/2019Roth CapitalInitiated CoverageBuy ➝ Buy$4.50High
5/21/2019Barrington ResearchReiterated RatingBuy$4.50High
10/25/2018Barrington ResearchSet TargetBuy$5.00Medium
4/30/2018Stifel NicolausDowngradeBuy ➝ Hold$6.00 ➝ $4.00Medium
(Data available from 1/29/2018 forward)

News Sentiment Rating

0.64 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
7/3/2022
  • 6 very positive mentions
  • 5 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
8/2/2022
  • 3 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/1/2022
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/1/2022
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/31/2022
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/30/2022
  • 1 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/30/2022
  • 1 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
1/29/2023

Current Sentiment

  • 1 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.
Sharps Compliance logo
Sharps Compliance Corp. provides medical, pharmaceutical, and hazardous waste management services in the United States. It offers Sharps Recovery System for the containment, transportation, treatment, and tracking of medical waste generated outside the hospital and health care facility settings; TakeAway Recovery System to treat used needles, syringes, and other used healthcare products; Route-Based Pickup Service, a medical and hazardous waste pick-up services; and MedSafe, a solution for the safe collection, transportation, and disposal of unwanted and expired ultimate-user medications. The company also provides TakeAway Medication Recovery System that facilitates the proper disposal of unused medications; Black Pail Program for Rx, a solution with minimal segregation for the disposal of various pharmaceuticals; Inhaler Disposal to collect, transport, and destroy used pharmaceutical inhalers; Hazardous Drug Spill Control Kit for the cleanup of chemotherapy and other HD spills; TakeAway Recycle System for the collection and recycling of single-use medical devices from surgical centers and other healthcare facilities; ComplianceTRAC, a Web-based compliance and training program; and Universal Waste Shipback Systems to collect, transport, and recycle light bulbs, batteries, and other mercury containing devices. In addition, it offers other solutions, such as TakeAway Environmental Return System, SharpsTracer, Sharps Secure, Needle Disposal System, Complete Needle Collection and Disposal System, Pitch-It IV Poles, Asset Return System, and Spill Kit Recovery System, as well as Sharps MWMS, a medical waste management system. The company serves customers in home health care, retail clinics and immunizing pharmacies, pharmaceutical manufacturers, professional offices, assisted living and long-term care facilities, and government agencies, as well as distributors. Sharps Compliance Corp. was founded in 1992 and is headquartered in Houston, Texas.
Read More

Today's Range

Now: $8.75
Low: $8.75
High: $8.75

50 Day Range

MA: $8.73
Low: $8.64
High: $8.75

52 Week Range

Now: $8.75
Low: $2.83
High: $9.66

Volume

368 shs

Average Volume

230,561 shs

Market Capitalization

$170.01 million

P/E Ratio

28.23

Dividend Yield

N/A

Beta

1.28

Frequently Asked Questions

What sell-side analysts currently cover shares of Sharps Compliance?

The following Wall Street sell-side analysts have issued research reports on Sharps Compliance in the last twelve months: Barrington Research, Lake Street Capital, Roth Capital, Stifel Nicolaus, and StockNews.com.
View the latest analyst ratings for SMED.

What is the current price target for Sharps Compliance?

2 Wall Street analysts have set twelve-month price targets for Sharps Compliance in the last year. Their average twelve-month price target is $6.50, suggesting a possible downside of 25.7%. Roth Capital has the highest price target set, predicting SMED will reach $7.00 in the next twelve months. Barrington Research has the lowest price target set, forecasting a price of $6.00 for Sharps Compliance in the next year.
View the latest price targets for SMED.

What is the current consensus analyst rating for Sharps Compliance?

Sharps Compliance currently has 4 hold ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in SMED, but not buy more shares or sell existing shares.
View the latest ratings for SMED.

What other companies compete with Sharps Compliance?

How do I contact Sharps Compliance's investor relations team?

Sharps Compliance's physical mailing address is 9220 KIRBY DRIVE STE 500, HOUSTON TX, 77054. The industrial products company's listed phone number is (713) 432-0300 and its investor relations email address is [email protected] The official website for Sharps Compliance is www.sharpsinc.com. Learn More about contacing Sharps Compliance investor relations.